SCHEMBL19249347

SCHEMBL19249347

N=Cc1c(N)cc(Br)cc1NCc1ccc(C(=O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ CTDSP1 Q9GZU7 1/20 0.45
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39
▸ RXRG P48443 1/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ HDAC1 Q13547 3/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ NCOR2 Q9Y618 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19249261 0.85 IDO1 (0.36) L3MBTL1KMT2AMEN1MAPT
SCHEMBL22084443 0.84 BACE1 (0.40) HPGDHSD17B10HDAC1KDM4EGAA
SCHEMBL19248996 0.81 HDAC1 (0.45) POLBKMT2AMEN1HDAC1HDAC3
SCHEMBL9194246 0.70 ALDH1A1 (0.69) ALDH1A1L3MBTL1HPGDPOLBHSD17B10
SCHEMBL14000510 0.70 ALDH1A1 (0.64) ALDH1A1L3MBTL1HPGDPOLBHSD17B10
SCHEMBL22083883 0.69 RORC (0.40) ALDH1A1KMT2AMEN1HDAC1HDAC3
SCHEMBL28470020 0.69 ALDH1A1 (0.58) ALDH1A1L3MBTL1HPGDPOLBHSD17B10
SCHEMBL22083949 0.68 TAAR1 (0.35) —
SCHEMBL19249090 0.68 TDP1 (0.33) —
SCHEMBL22084441 0.68 POLB (0.48) POLBKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133258-A1 1H-INDAZOLE DERIVATIVE AND USE THEREOF AS IDO INHIBITOR 西华大学 2017-08-10 — — WO disclosed
Send feedback